Back

G protein subtype preference dictates paroxetine-enhanced serotonin receptor response in normal breast epithelial cells

Lengyel, M.; Arkosy, P.; Uray, I. P.

2025-06-16 pharmacology and toxicology
10.1101/2025.06.10.658790 bioRxiv
Show abstract

In the healthy mammary gland serotonin (5-HT) has a key role in shaping tissue morphology and regulating lactation and involution. Serotonin re-uptake inhibitors (SSRIs) alter the distribution of 5-HT across the cell membrane, but how increased extracellular 5-HT may impact breast cell homeostasis is unclear. We demonstrate that paroxetine reduces 5-HT levels in immortalized primary breast epithelial (HME-hTert) cells, mitigates free oxygen radical formation and decreases cell migration and proliferation. Accordingly, pathways related to cell cycle and DNA damage repair were underrepresented in the transciptomic profile of paroxetine-treated cells. On the other hand, enriched transcipts overrepresented genes affecting neural transmission and GPCR signaling, suggesting an increase in 5-HT receptor (5HTR) activation. As 5-HT induced the levels of both cAMP and inositol triphosphate (IP3), the contribution of individual 5HTRs were decyphered using receptor-selective agonists and antagonists. 5HTRs coupled to each G protein subtype were expressed and functional in HME-hTert cells. The activation of GS-coupled receptor 5HTR7 and antagonists of Gi- and Gq-coupled receptors 5HTR1D and 5HTR2B generally suppressed proliferation. The induction of cAMP levels by 5-HT was reduced by the 5HTR7 antagonist and IP3 induction was blocked by an 5HTR2B inhibitor, while the 5HTR1D antagonist further increased cAMP levels induced by 5-HT. Paroxetine-dependent growth suppression was reversed by inhibitors of GS-coupled 5HTR7, protein kinase A or adenylyl cyclase, and agonists of Gi or Gq-coupled receptors. These results suggest that the anti-proliferative responses to 5-HT in non-malignant breast cells align with the G protein preference of the receptors, and reveal potential benefits of repurposing receptor subtype-selective agents and SSRIs for cancer risk reduction. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=151 SRC="FIGDIR/small/658790v1_ufig1.gif" ALT="Figure 1"> View larger version (30K): org.highwire.dtl.DTLVardef@1a4e2a4org.highwire.dtl.DTLVardef@1b9ea7org.highwire.dtl.DTLVardef@14cfe9dorg.highwire.dtl.DTLVardef@1e02960_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.